• Contact Us
  • Our Team
  • What we do
  • Our process
  • Media Centre
  • Work With Us
h2o
  • Home >
  • Sitemap

Sitemap

  • H20 Ventures
  • Our Team
    • The Team
    • Oxford
    • Kigali
      • Dr. David Kelly
      • Dr. Paul Coleman
      • Frances Thomson
      • Joshua Rugema
      • Eugene Ruzigana
      • Christian Heremans
      • Rakesh Apte
      • Alex Handy
      • Isha Javeri
      • Alice Wang
      • Afsah Feroz
      • Laura Brouwer
  • What we do
    • Agriculture
      • Case Study – Sarura Commodities
    • Health
      • Case Study: Eykona Technologies
    • Environment
      • Case study: Microbial solutions
  • Our Process
    • Real need
    • Real opportunity
    • Real expertise
    • Real returns
  • Media Centre
  • News
    • Rwanda is ninth fastest growing economy globally
    • H2O Sells 360 Genomics for £1.6m + £8m (up-front + earn-out)
    • Justine Greening: Investing in growth. How DFID works in new and emerging markets.
    • Oxitec recognised by prestigious Frost and Sullivan award for its pioneering system of pest control.
    • Gorilla Honey launches fundraising campaign on Indiegogo
    • H2O Contributes to New Study on Development Impact Bonds
    • H2O Appointed Principal Advisor to New Cancer Fund
    • Rockefeller: Sarura Commodities “Leading Catalytic Innovation” in African Agriculture
    • Panama says ‘GO’ to GM mosquito evaluation
    • Oxitec features in the Telegraph 1000: Britian’s Brightest Businesses
    • Wired 2013 video: Oxitec’s Hadyn Parry on tackling dengue fever with genetically-modified mosquitoes
    • Moscamed launches urban scale project using Oxitec GM mosquitoes in battle against dengue
    • Oxitec report 96% suppression of the dengue mosquito in Brazilian trials
    • Eykona Medical reports its inclusion on the NHS Supply Chain product range
    • Sarura Commodities Secures Contract with World Food Programme ‘Purchase for Progress’
    • Fuel3D smashes Kickstarter goal; validates vision for affordable 3D scanning
    • Fuel3D secures $2.6 million initial investment
    • Sarura Secures US$415,000 in Growth Financing from Leading Impact Lender
    • Citizen Bird: thinking, inside the box!
    • BACIT, CRT Pioneer fund and SAREUM enter agreement to fund development of drugs
    • Oxitec: Luke Alphey wins BBSRC Innovator of the Year 2014
    • Fuel3D wins £685k contract for development of medical imaging system
    • H2O: DfID backs first-in-class development bond
    • Sarura Secures First-in-Class Inventory Credit Financing from Leading Commercial Bank
    • Oxitec: Brazil approves general commercial release of Oxitec's GM mosquitoes
    • Oxitec do Brasil opens its first mosquito production unit to fight the dengue vector, Aedes aegypti
    • CLOSED: Technology Scouting (Agriculture & Development), Oxford
    • OXITEC: Completes Oversubscribed £6.1 Million ($10.2 Million) Fundraising
    • CLOSED: Investor & Volunteer Relations, Oxford
    • PointMan: new data suggest possibility of simple blood test for cancers
    • H2O RECRUITING: Business Development Managers, Kigali
    • Fuel3D Scanner (beta) units have begun shipping!
    • PointMan: US Research Collaboration to Develop Blood Tests for Cancer Patients
    • PointMan: US Research Collaboration to Develop Blood Tests for Cancer Patients
    • Fuel3D secures $6.4 million in expansion funding
    • Fuel3D wins CES Best of Innovation Award
    • Fuel3D Launches SCANIFY at 2015 International CES
    • Structured Eye Ltd: Royal Society grant to develop Ophthalmoscope
    • Chariot: Structured Eye Ltd spins out from City University
    • Oxitec: Panama pilot achieves over 90% control of dengue vector
    • PointMan: EKF announces Angle collaboration
    • Fuel3D Announces SCANIFY Retail Availability
    • Fuel3D Opens San Francisco Office
    • Oxitec: City of Piracicaba begins release of ‘Friendly Aedes aegypti’
    • PointMan: detects blood marker of lung cancer therapy resistance.
    • Microbial Solutions: Successfully Closes Funding Round
    • Oxitec: ‘self-limiting gene’ for controlling invasive moths.
    • Oxitec: Intrexon Inc. Acquires Oxitec for US$160 million
    • Oxitec: Wins Best Emerging UK Synbio Company Award
    • Oxitec: World Health Organization Issues Positive Recommendation
    • Oxitec: FDA Publishes Preliminary Finding of No Significant Impact
    • Oxitec: Expansion of Programmes Attacking Zika and Dengue
    • Oxitec: Australia trials medfly for protection of fruit crops
    • Fuel3D: new 3D algorithm boosts performance
    • Fuel3D: enterprise 3D scanning innovations at CES 2016
    • Fuel3D: shortlisted for Innovate UK award
    • EKF: results from PointMan / Mass Gen Hospital study
    • Oxitec Named Social Impact Investment of the Year
    • Oxitec: Dengue fever cases drop 91% where Oxitec’s Friendly™ Aedes were released
  • Video
  • Work With Us
  • Search
  • Sitemap
  • Disclaimer
  • Accessibility
  • Contact Us
  • Terms of Website Use
  • vimeo
  • facboook
  • rss
  • twitter
  • linkedin

Our Team

  • The Team
  • Oxford
  • Kigali

What we do

  • Agriculture
  • Health
  • Environment

Our process

  • Real need
  • Real opportunity
  • Real expertise
  • Real returns

Media Centre

Contacts

UK Headquarters
33-35 George Street
Oxford
OX1 2AY
United Kingdom


Telephone
+44 (0)1865 251 000
Fax
+44 (0)1865 204 114

  • Sitemap
  • Disclaimer
  • Terms of Use
    • -
  • Accessibility
  • ©H2OVP 2017